IL126625A0 - 6-o-substituted erythromycin compounds and method for making same - Google Patents

6-o-substituted erythromycin compounds and method for making same

Info

Publication number
IL126625A0
IL126625A0 IL12662597A IL12662597A IL126625A0 IL 126625 A0 IL126625 A0 IL 126625A0 IL 12662597 A IL12662597 A IL 12662597A IL 12662597 A IL12662597 A IL 12662597A IL 126625 A0 IL126625 A0 IL 126625A0
Authority
IL
Israel
Prior art keywords
compounds
making same
substituted erythromycin
erythromycin compounds
substituted
Prior art date
Application number
IL12662597A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/841,038 external-priority patent/US6075011A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL126625A0 publication Critical patent/IL126625A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12662597A 1996-05-07 1997-05-06 6-o-substituted erythromycin compounds and method for making same IL126625A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64647796A 1996-05-07 1996-05-07
US08/841,038 US6075011A (en) 1996-05-07 1997-04-29 6-O-substituted erythromycin compounds and method for making same
PCT/US1997/007702 WO1997042206A1 (fr) 1996-05-07 1997-05-06 Composes a base d'erythromycine 6-0 substituee et technique de production

Publications (1)

Publication Number Publication Date
IL126625A0 true IL126625A0 (en) 1999-08-17

Family

ID=27094941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12662597A IL126625A0 (en) 1996-05-07 1997-05-06 6-o-substituted erythromycin compounds and method for making same

Country Status (12)

Country Link
EP (1) EP1007530B1 (fr)
AT (1) ATE310010T1 (fr)
AU (1) AU726075B2 (fr)
BR (1) BR9708929A (fr)
CA (1) CA2253330C (fr)
CZ (1) CZ351898A3 (fr)
DE (1) DE69734678T2 (fr)
DK (1) DK1007530T3 (fr)
ES (1) ES2252784T3 (fr)
IL (1) IL126625A0 (fr)
NZ (1) NZ332320A (fr)
WO (1) WO1997042206A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018808A1 (fr) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine
JP2000198795A (ja) * 1996-10-31 2000-07-18 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
EP0895999A1 (fr) 1997-08-06 1999-02-10 Pfizer Products Inc. Macrolides antibiotiques substitués C"-4
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6395710B1 (en) * 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000071557A1 (fr) * 1999-05-24 2000-11-30 Pfizer Products Inc. Derives de 13-methyl-erythromycine
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US11420995B2 (en) 2017-03-03 2022-08-23 Synovo Gmbh Anti-infective and anti-inflammatory compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
ES2252784T3 (es) 2006-05-16
NZ332320A (en) 2000-07-28
CA2253330A1 (fr) 1997-11-13
CZ351898A3 (cs) 1999-04-14
AU726075B2 (en) 2000-10-26
BR9708929A (pt) 1999-08-03
WO1997042206A1 (fr) 1997-11-13
DE69734678D1 (de) 2005-12-22
CA2253330C (fr) 2006-07-25
EP1007530B1 (fr) 2005-11-16
EP1007530A1 (fr) 2000-06-14
ATE310010T1 (de) 2005-12-15
DE69734678T2 (de) 2006-08-17
AU2998797A (en) 1997-11-26
DK1007530T3 (da) 2006-04-03

Similar Documents

Publication Publication Date Title
CA2253338A1 (fr) Erythromycines 6-o substituees et leur procede de preparation
CA2263972A1 (fr) Cetolides substitues en 6-o possedant une activite antibacterienne
YU11699A (sh) 6-supstituisani ketolidi koji imaju antibakterijsko dejstvo, postupci za njihovo dobijanje i njihovi farmaceutski preparati
CA2359708A1 (fr) Antibiotiques cetolides
CA2292359A1 (fr) Nouveaux azalides et procede de fabrication
WO2003004509A3 (fr) Macrolides et cetolides d'erythromycine modifiee c12 a activite antibacterienne
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
WO2000026224A3 (fr) Nouveaux antibiotiques macrolide
CA2372270A1 (fr) Derives de l'erythromicine c-2 modifiee
AU6484199A (en) Carbamate and carbazate ketolide antibiotics
CA2351429A1 (fr) Azalides a 13 elements et leur utilisation en tant qu'antibiotiques
PT876388E (pt) Derivados de eritromicina triciclica
IL126625A0 (en) 6-o-substituted erythromycin compounds and method for making same
WO2004096823A3 (fr) Nouveaux derives de ketolides
CA2483875A1 (fr) Derives de l'erythromycine 6,11 bicyclique
CA2351829A1 (fr) Antibiotiques macrolides
CA2564020A1 (fr) Cetolides substitues en 6-o possedant une activite antibacterienne
IL123386A0 (en) 3-Deoxy-3-descladinose derivatives of erythromycins
BG103985A (en) Multicyclic derivatives of erythromycin